Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVanquis Banking Regulatory News (VANQ)

Share Price Information for Vanquis Banking (VANQ)

Share Price is delayed by 15 minutes
Get Live Data
117.00    -0.40 (-0.34%)
Bid:
117.00
Ask:
117.60
Spread: 0.60 (0.513%)
Market Cap: £292.89m
VANQ Live PriceLast checked at - London Stock Exchange

Intraday Vanquis Banking Share Chart

Director/PDMR Shareholding

20 Mar 2025 10:18

RNS Number : 5024B
Vanquis Banking Group PLC
20 March 2025
Β 

Vanquis Banking Group plc ("the Company")

Director/PDMR Transaction - Initial Notification

Β 

The Company announces the following transactions in the Company's Ordinary Shares of 20 8/11p ("Ordinary Shares") undertaken by directors / persons discharging managerial responsibility ('PDMRs') and their persons closely associated ('PCAs').

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Dave Watts

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Vanquis Banking Group plc

b)

Β 

LEI

Β 

213800U93SZC44VXN635

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary Shares of 20 8/11p

Β 

GB00B1Z4ST84

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Market purchase of 40,000 Ordinary Shares.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.57062

40,000

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

N/A (Single transaction)

e)

Β 

Date of the transaction

19 March 2025

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Name of authorised official of issuer responsible for making notification:

Elizabeth McClure, Deputy Company Secretary

Date of Notification:

20 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBBLFLEXLFBBV
Date   Source Headline
16th Oct 20254:00 pmRNSDirector/PDMR Shareholding
13th Oct 20258:30 amRNSHolding(s) in Company
10th Oct 20254:00 pmRNSDirector/PDMR Shareholding
1st Oct 202511:37 amRNSIssuance of AT1 Notes and Tender of Tier 2 Notes
1st Oct 20259:14 amRNSTender Offer Final Results
30th Sep 20254:30 pmRNSTotal Voting Rights
29th Sep 20253:00 pmRNSPublication of Offering Circular
23rd Sep 20253:06 pmRNSTender Offer - Maximum Acceptance
23rd Sep 20258:12 amRNSTender Offer
16th Sep 20254:00 pmRNSDirector/PDMR Shareholding
10th Sep 202510:30 amRNSDirector/PDMR Shareholding
29th Aug 20254:30 pmRNSTotal Voting Rights
29th Aug 20258:45 amRNSHolding(s) in Company
21st Aug 20259:40 amRNSHolding(s) in Company
15th Aug 20254:00 pmRNSDirector/PDMR Shareholding
12th Aug 202512:00 pmRNSHolding(s) in Company
7th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
5th Aug 202512:15 pmRNSHolding(s) in Company
31st Jul 20254:30 pmRNSTotal Voting Rights
16th Jul 20254:00 pmRNSDirector/PDMR Shareholding
15th Jul 20253:00 pmRNSBlock listing Interim Review
11th Jul 20257:00 amRNSVanquis Banking Group Reporting Changes
9th Jul 20253:53 pmRNSHolding(s) in Company
1st Jul 20254:00 pmRNSNotice of Interim Results & Investor Presentations
30th Jun 20254:30 pmRNSTotal Voting Rights
17th Jun 20254:00 pmRNSDirector/PDMR Shareholding
30th May 20254:30 pmRNSTotal Voting Rights
15th May 20254:00 pmRNSDirector/PDMR Shareholding
14th May 20252:30 pmRNSResult of AGM
14th May 20257:00 amRNSFirst quarter trading statement
30th Apr 20254:00 pmRNSTotal Voting Rights
15th Apr 20254:00 pmRNSDirector/PDMR Shareholding
1st Apr 20253:36 pmRNSHolding(s) in Company
31st Mar 20254:30 pmRNSTotal Voting Rights
25th Mar 20253:03 pmRNSHolding(s) in Company
20th Mar 202510:18 amRNSDirector/PDMR Shareholding
17th Mar 20254:39 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSResults for the year ended 31 December 2024
14th Mar 20257:00 amRNSPublication of 2024 Annual Report and AGM Notice
28th Feb 20254:30 pmRNSTotal Voting Rights
18th Feb 20259:23 amRNSHolding(s) in Company
17th Feb 20254:00 pmRNSDirector/PDMR Shareholding
5th Feb 202510:45 amRNSHolding(s) in Company
31st Jan 20254:30 pmRNSTotal Voting Rights
29th Jan 20253:00 pmRNSDirectorate Change
15th Jan 20254:00 pmRNSDirector/PDMR Shareholding
15th Jan 20253:04 pmRNSBlock listing Interim Review
9th Jan 202511:50 amRNSHolding(s) in Company
2nd Jan 20259:42 amRNSTotal Voting Rights
17th Dec 20244:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.